VAERS reports by lot

GSK DTaP/Tdap lot GC5NG: VAERS reports

32 VAERS reports list lot GC5NG as a GSK DTaP/Tdap vaccine, received between 2021-08-07 and 2023-11-28. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1229%
Musculoskeletal922%
Injection-site / Local reaction820%
Dermatological (non-injection-site)512%
Neurological37%
Cardiac / Cardiovascular25%
Respiratory12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California8
Illinois4
Georgia2
Texas2
Oklahoma2
Rhode Island2
Missouri1
North Carolina1
Oregon1
Montana1
Arkansas1
New Jersey1

Reports by month received

MonthReportsBar
2021-085
2021-093
2021-102
2021-117
2021-125
2022-011
2022-032
2022-042
2022-111
2023-042
2023-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): G5BE3 · G9N2M · GA5Z5 · GG39D · H242K · H4279

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.